Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II
Open Access
- 1 February 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 97 (3) , 777-784
- https://doi.org/10.1182/blood.v97.3.777
Abstract
Genetic evidence demonstrates the importance of plasminogen activation in the migration of macrophages to sites of injury and inflammation, their removal of necrotic debris, and their clearance of fibrin. These studies identified the plasminogen binding protein annexin II on the surface of macrophages and determined its role in their ability to degrade and migrate through extracellular matrices. Calcium-dependent binding of annexin II to RAW264.7 macrophages was shown using flow cytometry and Western blot analysis of EGTA eluates. Ligand blots demonstrated that annexin II comigrates with one of several proteins in lysates and membranes derived from RAW264.7 macrophages that bind plasminogen. Preincubation of RAW264.7 macrophages with monoclonal anti–annexin II IgG inhibited (35%) their binding of 125I-Lys-plasminogen. Likewise, plasmin binding to human monocyte-derived macrophages and THP-1 monocytes was inhibited (50% and 35%, respectively) when cells were preincubated with anti–annexin II IgG. Inhibition of plasminogen binding to annexin II on RAW264.7 macrophages significantly impaired their ability to activate plasminogen and degrade [3H]-glucosamine–labeled extracellular matrices. The migration of THP-1 monocytes through a porous membrane, in response to monocyte chemotactic protein-1, was blocked when the membranes were coated with extracellular matrix. The addition of plasminogen to the monocytes restored their ability to migrate through the matrix-coated membrane. Preincubation of THP-1 monocytes with anti–annexin II IgG inhibited (60%) their plasminogen-dependent chemotaxis through the extracellular matrix. These studies identify annexin II as a plasminogen binding site on macrophages and indicate an important role for annexin II in their invasive and degradative phenotype.Keywords
This publication has 63 references indexed in Scilit:
- S-100 Protein and Annexin II2-p112 (Calpactin I) Act in Concert to Regulate the State of Assembly of GFAP Intermediate Filaments in VitroBiochemical and Biophysical Research Communications, 1995
- Regulation of Plasminogen Activator Inhibitor-1 Levels in Human MonocytesCellular Immunology, 1993
- Plasminogen‐binding protein associated with the plasma membrane of cultured embryonic rat neocortical neuronsFEBS Letters, 1993
- Transforming growth factor‐β1 stimulates macrophage urokinase expression and release of matrix‐bound basic fibroblast growth factorJournal of Cellular Physiology, 1993
- Identification of a key domain in annexin and 14‐3‐3 proteins that stimulate calcium‐dependent exocytosis in permeabilized adrenal chromaffin cellsFEBS Letters, 1993
- Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cellsClinical & Experimental Metastasis, 1993
- The binding of plasminogen fragments to cultured human umbilical vein endothelial cellsBiochemical and Biophysical Research Communications, 1992
- Binding of Lys-plasminogen to monocytes/macrophages.Journal of Clinical Investigation, 1988
- Degradation of connective tissue matrices by macrophages. III. Morphological and biochemical studies on extracellular, pericellular, and intracellular events in matrix proteolysis by macrophages in culture.The Journal of Experimental Medicine, 1980
- Functional macrophage cell lines transformed by abelson leukemia virusCell, 1978